Marshall & Sterling Wealth Advisors Inc.
Position in ABBV — AbbVie Inc.
CIK 2056315
POUGHKEEPSIE, NY
Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$442,886
+$89,030 QoQ
Shares Held
1,760
+8.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#3,282
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Marshall & Sterling Wealth Advisors Inc. holds $1,416,991 across 9 Drug Manufacturers - General names. ABBV ranks #2 (31.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
2,071 | $749,950 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,760 | $442,886 | |
| 3 | NVS |
Novartis AG
|
518 | $81,180 | |
| 4 | MRK |
Merck & Co., Inc.
|
463 | $59,495 | |
| 5 | LLY |
ELI LILLY & Co
|
40 | $47,977 | |
| 6 | NVO |
Novo Nordisk A S
|
223 | $10,690 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
71 | $8,970 | |
| 8 | PFE |
Pfizer Inc
|
331 | $7,970 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,886 | 1,760 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $353,856 | 1,627 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $411,282 | 1,800 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $369,059 | 1,594 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $320,549 | 1,727 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $359,940 | 1,718 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $305,821 | 1,721 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||